SidaGhanaV1, PascalFrancis, Corpus, bibRecord, 000014

Sex differences in HIV testing in Ghana, and policy implications

Identifieur interne : 000014 ( PascalFrancis/Corpus ); précédent : 000013; suivant : 000015

Sex differences in HIV testing in Ghana, and policy implications

Auteurs : Alfred E. Yawson ; Phyllis Dako-Gyeke ; Rachel Snow

Source :

AIDS Care : (Print) [ 0954-0121 ] ; 2012.

RBID : Pascal:12-0413578

Descripteurs français

Pascal (Inist)
- Sexe, Dépistage, Sérologie, SIDA, Ghana, Politique sanitaire, Virus immunodéficience humaine, Maladie sexuellement transmissible, Santé mentale, Environnement social, Facteur sociodémographique, Prévention, Homme.

English descriptors

KwdEn :
- AIDS, Ghana, Health policy, Human, Human immunodeficiency virus, Medical screening, Mental health, Prevention, Serology, Sex, Sexually transmitted disease, Social environment, Sociodemographic factor.

Abstract

HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

A01	`01`	`1`		`@0 0954-0121`
A03		`1`		`@0 AIDS Care : (Print)`
A05				`@2 24`
A06				`@2 9-10`
A08	`01`	`1`	`ENG`	`@1 Sex differences in HIV testing in Ghana, and policy implications`
A11	`01`	`1`		`@1 YAWSON (Alfred E.)`
A11	`02`	`1`		`@1 DAKO-GYEKE (Phyllis)`
A11	`03`	`1`		`@1 SNOW (Rachel)`
A14	`01`			`@1 Department of Community Health, University of Ghana Medical School @2 Accra @3 GHA @Z 1 aut.`
A14	`02`			`@1 National AIDS/STI Control Programme, Ghana Health Service @2 Accra @3 GHA @Z 1 aut.`
A14	`03`			`@1 Department of Social and Behavioral Sciences, University of Ghana Accra @3 GHA @Z 2 aut.`
A14	`04`			`@1 Department of Health Behavior and Health Education, University of Michigan @2 Ann Arbor, MI @3 USA @Z 3 aut.`
A20				`@1 1181-1185`
A21				`@1 2012`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 22096 @5 354000504405780170`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 3/4 p.`
A47	`01`	`1`		`@0 12-0413578`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 AIDS Care : (Print)`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.
C02	`01`	`X`		`@0 002B05C02D`
C02	`02`	`X`		`@0 002B06D01`
C02	`03`	`X`		`@0 002B18H05A`
C03	`01`	`X`	`FRE`	`@0 Sexe @5 01`
C03	`01`	`X`	`ENG`	`@0 Sex @5 01`
C03	`01`	`X`	`SPA`	`@0 Sexo @5 01`
C03	`02`	`X`	`FRE`	`@0 Dépistage @5 02`
C03	`02`	`X`	`ENG`	`@0 Medical screening @5 02`
C03	`02`	`X`	`SPA`	`@0 Descubrimiento @5 02`
C03	`03`	`X`	`FRE`	`@0 Sérologie @5 03`
C03	`03`	`X`	`ENG`	`@0 Serology @5 03`
C03	`03`	`X`	`SPA`	`@0 Serología @5 03`
C03	`04`	`X`	`FRE`	`@0 SIDA @5 04`
C03	`04`	`X`	`ENG`	`@0 AIDS @5 04`
C03	`04`	`X`	`SPA`	`@0 SIDA @5 04`
C03	`05`	`X`	`FRE`	`@0 Ghana @2 NG @5 05`
C03	`05`	`X`	`ENG`	`@0 Ghana @2 NG @5 05`
C03	`05`	`X`	`SPA`	`@0 Ghana @2 NG @5 05`
C03	`06`	`X`	`FRE`	`@0 Politique sanitaire @5 06`
C03	`06`	`X`	`ENG`	`@0 Health policy @5 06`
C03	`06`	`X`	`SPA`	`@0 Política sanitaria @5 06`
C03	`07`	`X`	`FRE`	`@0 Virus immunodéficience humaine @2 NW @5 07`
C03	`07`	`X`	`ENG`	`@0 Human immunodeficiency virus @2 NW @5 07`
C03	`07`	`X`	`SPA`	`@0 Human immunodeficiency virus @2 NW @5 07`
C03	`08`	`X`	`FRE`	`@0 Maladie sexuellement transmissible @5 08`
C03	`08`	`X`	`ENG`	`@0 Sexually transmitted disease @5 08`
C03	`08`	`X`	`SPA`	`@0 Enfermedad de transmisión sexual @5 08`
C03	`09`	`X`	`FRE`	`@0 Santé mentale @5 09`
C03	`09`	`X`	`ENG`	`@0 Mental health @5 09`
C03	`09`	`X`	`SPA`	`@0 Salud mental @5 09`
C03	`10`	`X`	`FRE`	`@0 Environnement social @5 10`
C03	`10`	`X`	`ENG`	`@0 Social environment @5 10`
C03	`10`	`X`	`SPA`	`@0 Contexto social @5 10`
C03	`11`	`X`	`FRE`	`@0 Facteur sociodémographique @5 11`
C03	`11`	`X`	`ENG`	`@0 Sociodemographic factor @5 11`
C03	`11`	`X`	`SPA`	`@0 Factor sociodemográfico @5 11`
C03	`12`	`X`	`FRE`	`@0 Prévention @5 12`
C03	`12`	`X`	`ENG`	`@0 Prevention @5 12`
C03	`12`	`X`	`SPA`	`@0 Prevención @5 12`
C03	`13`	`X`	`FRE`	`@0 Homme @5 18`
C03	`13`	`X`	`ENG`	`@0 Human @5 18`
C03	`13`	`X`	`SPA`	`@0 Hombre @5 18`
C07	`01`	`X`	`FRE`	`@0 Virose`
C07	`01`	`X`	`ENG`	`@0 Viral disease`
C07	`01`	`X`	`SPA`	`@0 Virosis`
C07	`02`	`X`	`FRE`	`@0 Infection`
C07	`02`	`X`	`ENG`	`@0 Infection`
C07	`02`	`X`	`SPA`	`@0 Infección`
C07	`03`	`X`	`FRE`	`@0 Afrique @2 NG`
C07	`03`	`X`	`ENG`	`@0 Africa @2 NG`
C07	`03`	`X`	`SPA`	`@0 Africa @2 NG`
C07	`04`	`X`	`FRE`	`@0 Lentivirus @2 NW`
C07	`04`	`X`	`ENG`	`@0 Lentivirus @2 NW`
C07	`04`	`X`	`SPA`	`@0 Lentivirus @2 NW`
C07	`05`	`X`	`FRE`	`@0 Retroviridae @2 NW`
C07	`05`	`X`	`ENG`	`@0 Retroviridae @2 NW`
C07	`05`	`X`	`SPA`	`@0 Retroviridae @2 NW`
C07	`06`	`X`	`FRE`	`@0 Virus @2 NW`
C07	`06`	`X`	`ENG`	`@0 Virus @2 NW`
C07	`06`	`X`	`SPA`	`@0 Virus @2 NW`
C07	`07`	`X`	`FRE`	`@0 Immunodéficit @5 37`
C07	`07`	`X`	`ENG`	`@0 Immune deficiency @5 37`
C07	`07`	`X`	`SPA`	`@0 Inmunodeficiencia @5 37`
C07	`08`	`X`	`FRE`	`@0 Immunopathologie @5 39`
C07	`08`	`X`	`ENG`	`@0 Immunopathology @5 39`
C07	`08`	`X`	`SPA`	`@0 Inmunopatología @5 39`
C07	`09`	`X`	`FRE`	`@0 Santé publique @5 40`
C07	`09`	`X`	`ENG`	`@0 Public health @5 40`
C07	`09`	`X`	`SPA`	`@0 Salud pública @5 40`
N21				`@1 324`

Format Inist (serveur)

NO :	PASCAL 12-0413578 INIST
ET :	Sex differences in HIV testing in Ghana, and policy implications
AU :	YAWSON (Alfred E.); DAKO-GYEKE (Phyllis); SNOW (Rachel)
AF :	Department of Community Health, University of Ghana Medical School/Accra/Ghana (1 aut.); National AIDS/STI Control Programme, Ghana Health Service/Accra/Ghana (1 aut.); Department of Social and Behavioral Sciences, University of Ghana Accra/Ghana (2 aut.); Department of Health Behavior and Health Education, University of Michigan/Ann Arbor, MI/Etats-Unis (3 aut.)
DT :	Publication en série; Niveau analytique
SO :	AIDS Care : (Print); ISSN 0954-0121; Royaume-Uni; Da. 2012; Vol. 24; No. 9-10; Pp. 1181-1185; Bibl. 3/4 p.
LA :	Anglais
EA :	HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.
CC :	002B05C02D; 002B06D01; 002B18H05A
FD :	Sexe; Dépistage; Sérologie; SIDA; Ghana; Politique sanitaire; Virus immunodéficience humaine; Maladie sexuellement transmissible; Santé mentale; Environnement social; Facteur sociodémographique; Prévention; Homme
FG :	Virose; Infection; Afrique; Lentivirus; Retroviridae; Virus; Immunodéficit; Immunopathologie; Santé publique
ED :	Sex; Medical screening; Serology; AIDS; Ghana; Health policy; Human immunodeficiency virus; Sexually transmitted disease; Mental health; Social environment; Sociodemographic factor; Prevention; Human
EG :	Viral disease; Infection; Africa; Lentivirus; Retroviridae; Virus; Immune deficiency; Immunopathology; Public health
SD :	Sexo; Descubrimiento; Serología; SIDA; Ghana; Política sanitaria; Human immunodeficiency virus; Enfermedad de transmisión sexual; Salud mental; Contexto social; Factor sociodemográfico; Prevención; Hombre
LO :	INIST-22096.354000504405780170
ID :	12-0413578

Links to Exploration step

Pascal:12-0413578

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Sex differences in HIV testing in Ghana, and policy implications</title>
<author><name sortKey="Yawson, Alfred E" sort="Yawson, Alfred E" uniqKey="Yawson A" first="Alfred E." last="Yawson">Alfred E. Yawson</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Community Health, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>National AIDS/STI Control Programme, Ghana Health Service</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dako Gyeke, Phyllis" sort="Dako Gyeke, Phyllis" uniqKey="Dako Gyeke P" first="Phyllis" last="Dako-Gyeke">Phyllis Dako-Gyeke</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Social and Behavioral Sciences, University of Ghana Accra</s1>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Snow, Rachel" sort="Snow, Rachel" uniqKey="Snow R" first="Rachel" last="Snow">Rachel Snow</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Health Behavior and Health Education, University of Michigan</s1>
<s2>Ann Arbor, MI</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0413578</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0413578 INIST</idno>
<idno type="RBID">Pascal:12-0413578</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000014</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Sex differences in HIV testing in Ghana, and policy implications</title>
<author><name sortKey="Yawson, Alfred E" sort="Yawson, Alfred E" uniqKey="Yawson A" first="Alfred E." last="Yawson">Alfred E. Yawson</name>
<affiliation><inist:fA14 i1="01"><s1>Department of Community Health, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation><inist:fA14 i1="02"><s1>National AIDS/STI Control Programme, Ghana Health Service</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Dako Gyeke, Phyllis" sort="Dako Gyeke, Phyllis" uniqKey="Dako Gyeke P" first="Phyllis" last="Dako-Gyeke">Phyllis Dako-Gyeke</name>
<affiliation><inist:fA14 i1="03"><s1>Department of Social and Behavioral Sciences, University of Ghana Accra</s1>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author><name sortKey="Snow, Rachel" sort="Snow, Rachel" uniqKey="Snow R" first="Rachel" last="Snow">Rachel Snow</name>
<affiliation><inist:fA14 i1="04"><s1>Department of Health Behavior and Health Education, University of Michigan</s1>
<s2>Ann Arbor, MI</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">AIDS Care : (Print)</title>
<title level="j" type="abbreviated">AIDS Care : (Print)</title>
<idno type="ISSN">0954-0121</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">AIDS Care : (Print)</title>
<title level="j" type="abbreviated">AIDS Care : (Print)</title>
<idno type="ISSN">0954-0121</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>AIDS</term>
<term>Ghana</term>
<term>Health policy</term>
<term>Human</term>
<term>Human immunodeficiency virus</term>
<term>Medical screening</term>
<term>Mental health</term>
<term>Prevention</term>
<term>Serology</term>
<term>Sex</term>
<term>Sexually transmitted disease</term>
<term>Social environment</term>
<term>Sociodemographic factor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Sexe</term>
<term>Dépistage</term>
<term>Sérologie</term>
<term>SIDA</term>
<term>Ghana</term>
<term>Politique sanitaire</term>
<term>Virus immunodéficience humaine</term>
<term>Maladie sexuellement transmissible</term>
<term>Santé mentale</term>
<term>Environnement social</term>
<term>Facteur sociodémographique</term>
<term>Prévention</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0954-0121</s0>
</fA01>
<fA03 i2="1"><s0>AIDS Care : (Print)</s0>
</fA03>
<fA05><s2>24</s2>
</fA05>
<fA06><s2>9-10</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Sex differences in HIV testing in Ghana, and policy implications</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>YAWSON (Alfred E.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>DAKO-GYEKE (Phyllis)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SNOW (Rachel)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Community Health, University of Ghana Medical School</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>National AIDS/STI Control Programme, Ghana Health Service</s1>
<s2>Accra</s2>
<s3>GHA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Social and Behavioral Sciences, University of Ghana Accra</s1>
<s3>GHA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Health Behavior and Health Education, University of Michigan</s1>
<s2>Ann Arbor, MI</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20><s1>1181-1185</s1>
</fA20>
<fA21><s1>2012</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>22096</s2>
<s5>354000504405780170</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>3/4 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0413578</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>AIDS Care : (Print)</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B05C02D</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B06D01</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B18H05A</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Sexe</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Sex</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sexo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Dépistage</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Medical screening</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Descubrimiento</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Sérologie</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Serology</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Serología</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>SIDA</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>AIDS</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>SIDA</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Ghana</s0>
<s2>NG</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Ghana</s0>
<s2>NG</s2>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Ghana</s0>
<s2>NG</s2>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Politique sanitaire</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Health policy</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Política sanitaria</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Virus immunodéficience humaine</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Human immunodeficiency virus</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Maladie sexuellement transmissible</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Sexually transmitted disease</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Enfermedad de transmisión sexual</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Santé mentale</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Mental health</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Salud mental</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Environnement social</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Social environment</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Contexto social</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Facteur sociodémographique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Sociodemographic factor</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Factor sociodemográfico</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Prévention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Prevention</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Prevención</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Homme</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Human</s0>
<s5>18</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Hombre</s0>
<s5>18</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Virose</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Viral disease</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Virosis</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Infection</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Infección</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Afrique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Africa</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Lentivirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Retroviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Immunodéficit</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Immune deficiency</s0>
<s5>37</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Inmunodeficiencia</s0>
<s5>37</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Immunopathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Immunopathology</s0>
<s5>39</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Inmunopatología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Santé publique</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Public health</s0>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Salud pública</s0>
<s5>40</s5>
</fC07>
<fN21><s1>324</s1>
</fN21>
</pA>
</standard>
<server><NO>PASCAL 12-0413578 INIST</NO>
<ET>Sex differences in HIV testing in Ghana, and policy implications</ET>
<AU>YAWSON (Alfred E.); DAKO-GYEKE (Phyllis); SNOW (Rachel)</AU>
<AF>Department of Community Health, University of Ghana Medical School/Accra/Ghana (1 aut.); National AIDS/STI Control Programme, Ghana Health Service/Accra/Ghana (1 aut.); Department of Social and Behavioral Sciences, University of Ghana Accra/Ghana (2 aut.); Department of Health Behavior and Health Education, University of Michigan/Ann Arbor, MI/Etats-Unis (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>AIDS Care : (Print); ISSN 0954-0121; Royaume-Uni; Da. 2012; Vol. 24; No. 9-10; Pp. 1181-1185; Bibl. 3/4 p.</SO>
<LA>Anglais</LA>
<EA>HIV testing and counseling (HTC) is the primary gateway to all systems of AIDS-related care. This study describes sex differences in the use of HTC from data of the National AIDS/STI Control Program (NACP) over four years (2007-2010), across the 10 regions of Ghana. HTC data from NACP were from diagnostic centers (DCs), know your status campaigns (KYS) and prevention of mother-to-child transmission (PMTCT) sites across the country. Data highlight significantly greater use of HTC by females than males. From 2007 to 2010, females comprised 58.2% of all those using HIV testing at DCs and KYS, and this proportion rose to 75.9% when PMTCT data were included. The female: male testing ratio ranged from 6.2 in 2007 to 2.8 in 2010, suggesting a recent increase in male testing. The NACP data also indicate that females are more likely than males to test positive for HIV, suggesting either better catchment of HIV positive females, or potentially, a higher HIV epidemic among females than males. While the magnitude of the sex differences in testing varies by year and location, the data provide consistent evidence of lower male use of testing. Rigorous examination of HTC utilization rates, with closer attention to male use of testing, deserves closer policy attention.</EA>
<CC>002B05C02D; 002B06D01; 002B18H05A</CC>
<FD>Sexe; Dépistage; Sérologie; SIDA; Ghana; Politique sanitaire; Virus immunodéficience humaine; Maladie sexuellement transmissible; Santé mentale; Environnement social; Facteur sociodémographique; Prévention; Homme</FD>
<FG>Virose; Infection; Afrique; Lentivirus; Retroviridae; Virus; Immunodéficit; Immunopathologie; Santé publique</FG>
<ED>Sex; Medical screening; Serology; AIDS; Ghana; Health policy; Human immunodeficiency virus; Sexually transmitted disease; Mental health; Social environment; Sociodemographic factor; Prevention; Human</ED>
<EG>Viral disease; Infection; Africa; Lentivirus; Retroviridae; Virus; Immune deficiency; Immunopathology; Public health</EG>
<SD>Sexo; Descubrimiento; Serología; SIDA; Ghana; Política sanitaria; Human immunodeficiency virus; Enfermedad de transmisión sexual; Salud mental; Contexto social; Factor sociodemográfico; Prevención; Hombre</SD>
<LO>INIST-22096.354000504405780170</LO>
<ID>12-0413578</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/PascalFrancis/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000014 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000014 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaGhanaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:12-0413578
   |texte=   Sex differences in HIV testing in Ghana, and policy implications
}}

This area was generated with Dilib version V0.6.31.
Data generation: Tue Nov 7 18:07:38 2017. Site generation: Tue Mar 5 15:01:57 2024

	Le SIDA au Ghana (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Le SIDA au Ghana (serveur d'exploration)

Sex differences in HIV testing in Ghana, and policy implications

Sex differences in HIV testing in Ghana, and policy implications

Source :

Descripteurs français

English descriptors

Abstract

Notice en format standard (ISO 2709)

Format Inist (serveur)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri